The Rosalind and Morris Goodman Cancer Institute (GCI) has the pleasure of welcoming our new听Deputy Director, Dr. Trina Johnson.听In conjunction with the GCI Director,听Dr. Johnson听will develop and implement the strategic plans and business model听for the GCI.鈥�
Dr. Johnson鈥痺as selected after a thorough selection process that included听four听GCI investigators as well as other selection committee members from the听newly formed School of Biomedical Sciences (SBMS).听听
With听a Ph.D. in Biochemistry and Molecular Biology at the University of Calgary听specializing in听pre-clinical drug efficacy studies, neuro-immune pathogenesis and experimental therapies, Dr. Johnson is no stranger to听the world of听research.听Trina has firm roots in Montreal,听and has been a research associate听with Dr. Jack Antel and the Associate Director Scientific听and听Operations with the Experimental Therapeutics听Program, at The Montreal Neurological Institute (The Neuro). Her functions听at听The Neuro听were to develop and execute strategic business plans and to act as a clinical trial scientific director overseeing large budgets for cross-disciplinary听projects.鈥�
In 2015, Trina was recruited to Edmonton, Alberta where she first took a position as the Program Manager,听for the Alberta Clinical Research Consortium听at听Alberta Innovates and听then as听the Provincial Lead for Health Evidence and Innovation听at听Alberta Health Services听(AHS). In her position with AHS, Trina executed the implementation of Research as part of the provincial health record, making a patient鈥檚听participation听in research听visible听and听informative at all hospitals in Alberta. During her听mandate,听she听managed a large team of motivated health experts collaborating with IT, as well as operations,听research,听and administrative specialists.鈥�
The听position of Deputy Director听is being听made possible through听the GCI鈥檚听partnership with the newly formed School of Biomedical Sciences (SBMS) and the Faculty of Medicine and Health Sciences (FMHS).鈥�
Welcome听Dr. Johnson听to our听Institute!鈥�
听